Seminars in Immunology

Papers
(The TQCC of Seminars in Immunology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Editorial Board133
Exploiting antifungal immunity in the clinical context126
Differential immune responses behind different celiac disease manifestations96
Cellular stress and macrophage activation82
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells75
Accumulation of immune-suppressive CD4 + T cells in aging – tempering inflammaging at the expense of immunity66
Connecting the dots: Neutrophils at the interface of tissue regeneration and cancer56
They shall not grow mold: Soldiers of innate and adaptive immunity to fungi55
NGS data analysis for molecular diagnosis of Inborn Errors of Immunity53
Microbial metabolites and immunotherapy: Basic rationale and clinical indications50
Editorial Board50
Pyroptosis modulation by bacterial effector proteins48
Resolving inflammatory links between myocardial infarction and vascular dementia40
Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity39
Aging of lymphoid stromal architecture impacts immune responses39
Immunity to pathogenic fungi in the eye39
Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7)39
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity38
Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?38
The noncanonical inflammasome-induced pyroptosis and septic shock36
Pyroptosis and the cellular consequences of gasdermin pores35
Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease35
Pyroptosis: A road to next-generation cancer immunotherapy34
Interplay between the complement system and other immune pathways in the tumor microenvironment33
Introduction to the special issue: Neutrophils in the tumor microenvironment31
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment31
Cellular and molecular diversity in Sjogren’s syndrome salivary glands: Towards a better definition of disease subsets31
Western diet influences on microbiome and carcinogenesis31
Immunity to fungi: Editorial overview30
Neuroimmune interactions between itch neurons and skin microbes28
Specialized pro-resolving mediators as modulators of immune responses28
Cellular and molecular diversity in spondyloarthritis28
Introduction to the Special Issue: Nanoparticles and immune responses28
The evolving biology of cross-presentation28
TREM2: A new player in the tumor microenvironment26
Adaptive NK cell response to human cytomegalovirus: Facts and open issues25
Recent developments in C3-targeted complement therapeutics24
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases24
The paradox of aging: Aging-related shifts in T cell function and metabolism24
Antigen discovery for the development of cancer immunotherapy23
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy23
Sialic acid and Siglec receptors in tumor immunity and immunotherapy23
The dual role of neutrophils in cancer22
Thymus aging and immune reconstitution, progresses and challenges22
Introduction to the Special Issue: Nutrition, microbiota and immunity22
Complement C3-targeted therapy in C3 glomerulopathy, a prototype of complement-mediated kidney diseases21
T cell control of SARS-CoV-2: When, which, and where?21
Age-dependent changes in T follicular helper cells shape the humoral immune response to vaccination20
The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs20
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinic20
Empowering patients from within: Emerging nanomedicines for in vivo immune cell reprogramming20
The immunological processes behind aquaporin 4-antibody seropositive neuromyelitis optica spectrum disorders18
Introduction to the special issue: Complexity and diversity of immune responses in COVID-1918
What fungal CNS infections can teach us about neuroimmunology and CNS-specific immunity18
Targeting the tissue-complosome for curbing inflammatory disease18
Individual- and population-associated heterogeneity in vaccine-induced immune responses. The impact of inflammatory status and diabetic comorbidity18
Publisher's note: Welcome Prof. Guido Kroemer17
Epithelial inflammasomes, gasdermins, and mucosal inflammation – Lessons from Salmonella and Shigella infected mice17
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy17
T cell fate decisions during memory cell generation with aging17
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells17
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?17
Diversity of NF-κB signalling and inflammatory heterogeneity in Rheumatic Autoimmune Disease17
Promotion of trained innate immunity by nanoparticles17
0.074928045272827